Top Story

VIDEO: Results of LEADER trial may have ‘huge impact’ on patients with diabetes

August 26, 2016

Results of the LEADER trial demonstrated that treatment with liraglutide compared with placebo in patients with type 2 diabetes not only decreased cardiovascular death, but also decreased nonfatal stroke and nonfatal myocardial infarction.

In the Journals

Psoriasis, type 2 diabetes have similar association with coronary artery calcium

August 25, 2016
Patients with psoriasis had an association with coronary artery calcium that was similar to patients with type 2 diabetes, according to recent study results published in…
In the Journals Plus

Tight glycemic control benefits questionable for microvascular, macrovascular complications

August 24, 2016
Tight glycemic control confers no substantial benefit on the risk for microvascular or macrovascular complications, despite a consistent RR reduction for nonfatal…
In the Journals

Intracoronary abciximab may improve primary PCI in patients with diabetes, STEMI

August 17, 2016
Administration of an intracoronary bolus of abciximab improved outcomes of primary PCI compared with the IV bolus in patients with diabetes and STEMI, according to a…
In the Journals

Type 2 diabetes, prior CVD raise risk for CKD

June 9, 2016
Adults with long-standing type 2 diabetes and prior cardiovascular disease are more likely to have chronic kidney disease vs. patients without those…

In the Journals

Large initial weight loss mitigates CVD risk

June 9, 2016
A large initial weight loss can improve some risk factors for cardiovascular disease even if weight is regained, according to study findings…

Pharmacology Consult

New pharmacological therapies change management strategy for hyperkalemia

Cardiology Today, June 2016
TuTran Nguyen, PharmD, BCPS
Chronic kidney disease, defined as the presence of albuminuria or estimated glomerular filtration rate of less than 90 mL/min/1.73 m2, impairs the…

Meeting News Coverage

Two analyses show patiromer may benefit patients with HF

June 6, 2016
Two analyses presented at the 53rd European Renal Association – European Dialysis and Transplant Association Congress showed favorable…

Meeting News Coverage

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016
In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor…

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause…

Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the…

Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate…

Meeting News CoverageVideo

VIDEO: Breaks in sitting time reduce cardiometabolic risk factors in type 2 diabetes

May 4, 2016
ORLANDO, Fla. — Bronwyn Kingwell, PhD, head of metabolic and vascular physiology at Baker IDI Heart and Diabetes Institute, Melbourne…

Meeting News Coverage

Femoropopliteal DCB effective in women, patients with diabetes, CTO

May 4, 2016
A drug-coated balloon was effective in women, in patients with diabetes and in those with chronic total occlusions, according to new data. Analyses…

More Headlines »